Skip to content
Safety ProfileEvidence-Based

B-type Natriuretic Peptide (BNP) Side Effects

Honest, evidence-based safety analysis for B-type Natriuretic Peptide (BNP). Frequency data, severity classification, data limitations, and what we genuinely don't know.

Quick Answer

BNP's side effects vary based on whether it's being used for diagnosis or therapeutic purposes. Diagnostic BNP measurements are non-invasive and have no side effects. Therapeutic nesiritide can cause hypotension, headache, nausea, and renal impairment. Sacubitril/valsartan can cause hypotension, hyperkalemia, and angioedema.

Data Context: What We Actually Know

Important: data limitations

Side effect data for BNP primarily comes from clinical trials of nesiritide and sacubitril/valsartan. Individual responses may vary. Nesiritide use has declined due to lack of mortality benefit and concerns about renal effects. Close monitoring is crucial when administering nesiritide.

Side Effects by Severity

MildModerateSevere / Serious
HypotensionModerate

Frequency: Common

Most significant side effect with nesiritide. Requires careful blood pressure monitoring.

HeadacheMild

Frequency: Common

Transient and usually mild with nesiritide.

Renal ImpairmentSevere / Serious

Frequency: Uncommon

Observed with high doses of nesiritide. Monitor renal function.

NauseaMild

Frequency: Common

Mild and transient with nesiritide infusion.

HyperkalemiaModerate

Frequency: Uncommon

Monitor potassium levels with sacubitril/valsartan

AngioedemaSevere / Serious

Frequency: Rare

Potentially life-threatening. Discontinue medication immediately.

Contraindications

  • Hypotension (systolic BP <100 mmHg)
  • Known hypersensitivity to nesiritide or sacubitril/valsartan
  • Pregnancy and breastfeeding
  • Concurrent use of ACE inhibitors (for sacubitril/valsartan)

Drug Interactions

No formal pharmacokinetic drug interaction studies have been conducted for most research peptides. The interactions below are theoretical, mechanism-based, or derived from limited case reports.
  • ACE inhibitors: Increased risk of angioedema with sacubitril/valsartan
  • Vasodilators: Additive hypotensive effects
  • Diuretics: Increased risk of hypovolemia and electrolyte imbalances

Frequently Asked Questions

What are the most common side effects of nesiritide?
The most common side effect of nesiritide is hypotension. Headache and nausea are also frequently reported. Renal impairment is a less common but more serious concern.
Can BNP measurements themselves cause any side effects?
No. BNP measurement is a simple blood test and carries no direct side effects. The side effects are associated with the therapeutic use of nesiritide or sacubitril/valsartan.
What should I do if I experience hypotension while taking sacubitril/valsartan?
Inform your physician immediately. They may need to adjust the dose of sacubitril/valsartan or other medications that lower blood pressure.
How is renal function monitored when using nesiritide?
Renal function (creatinine, BUN) should be monitored during and after nesiritide infusion to detect any signs of renal impairment.
Is angioedema a common side effect of sacubitril/valsartan?
No, angioedema is a rare but serious side effect of sacubitril/valsartan. Seek immediate medical attention if you experience swelling of the face, lips, tongue, or throat.
Why has the use of nesiritide declined?
Nesiritide use has declined due to a lack of mortality benefit in clinical trials and concerns about potential renal toxicity. Sacubitril/valsartan has become the preferred treatment for heart failure with reduced ejection fraction.

References

  1. 1
    Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure (VMAC trial)(2002)PubMed ↗
  2. 2
    Angiotensin–neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF)(2014)PubMed ↗
  3. 3
    Nesiritide in patients with decompensated heart failure: a meta-analysis of randomised controlled trials(2005)PubMed ↗

Last updated: 2026-02-19